Resources for Health Professionals

COVID 19 treatment guidelines (US): April 8 Update

• Includes recommendations on which patients should and should not receive corticosteroids
• Hydroxychloroquine duration of therapy is now changed to 5 – 7 days
• The guidelines continue to recommend monotherapy hydroxychloroquine

Paralytic, sedation, and pain guidelines: April 8 Update

• These guidelines were developed with guidance from critical care and anesthesia, pharmacy and physicians.
• Benzodiazepines are first line when propofol isn’t available

Some questions are starting to rise regarding anticoagulation:

• According to the American Society of Hematology:
• Seriously ill COVID 19 patients should not receive therapeutic intensity anticoagulation empirically (ie in the absence of confirmed VTE).
• They should receive thromboprophylaxis only unless there is an indication for full therapeutic-intensity anticoagulation. Although therapeutic anticoagulation is recommended by some physicians in China because they have observed high rates of thrombosis in seriously ill people with COVID-19, these observations occurred in a setting where routine thromboprophylaxis may not be routinely practiced. In the U.S. or anywhere else where thromboprophylaxis is used for hospitalized patients, experts recommend using a standard approach to determine the need for pharmacologic prophylaxis and treatment, irrespective of COVID-19.
• Or order sets for COVID 19 include thromboprophylaxis

Specialty based resources

All Healthcare Professionals

Safety Chart

Suggestions to help minimize the risks to you and your loved ones at home. Created by Saima Husain.

DOD Practice Management Guide for COVID-19

Dated March 23, 2020. This Practice Management Guide does not supersede DoD Policy. It is based upon the best information available at the time of publication. It is designed to provide information and assist decision making. It is not intended to define a standard of care and should not be construed as one. Neither should it be interpreted as prescribing an exclusive course of management. It was developed by experts in this field. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of this guideline is responsible for evaluating the appropriateness of applying it in the setting of any particular clinical situation.

COVID-19: Nutraceuticial and Botanical Recommendations for Patients (Institute of Functional Medicine)

At this time, there are no specific vaccines or uniformly successful treatments for COVID-19. However, emerging research on several specific botanical and nutraceutical agents is promising, as such agents can improve the body’s ability to fight off and recover from the illness. Beneficial botanical and nutraceutical agents are listed below, along with dosing recommendations from your Functional Medicine practitioner. For more information on these recommendations, please consult your practitioner directly.

Mechanical Ventilation for COVID-19

This Harvard University free online course will provide licensed medical professionals with an understanding of mechanical ventilation so they can assist with the operation of mechanical ventilators during the COVID-19 pandemic.

Primary Care Providers (PCPs)

Algorithm for Primary Care Professionals to Direct Suspected COVID-19 Patients

Simple flow chart available at https://imamiamedics.com/assets/frontend/pdf/PCP-Direction-for-patients-2.pdf

The American Medical Association Physicians Guide

A quick-start physician guide to COVID-19, curated from comprehensive CDC, JAMA and WHO resources, that will help prepare your practice, address patient concerns and answer your most pressing questions. (https://imamiamedics.com/assets/frontend/pdf/physicians-guide-covid-19.pdf)

Cardiology

Added on April 10, 2020: Watch the Cardiology Grand Rounds at University of Washington (early epicenter) for the outbreak in the US: Covid-19 and the heart with pathology/autopsy findings (https://youtu.be/5JdqpLFdmhU)

Resources from April 1, 2020 or earlier:

https://imamiamedics.com/assets/editor_images/file/ACCSummaryofCOVID.docx

https://imamiamedics.com/assets/editor_images/file/CHS-Covid19-TreatmentGuidelines-JG-Draft2-Mar-18-2020.xlsx

https://imamiamedics.com/assets/frontend/pdf/S20028-ACC-Clinical-Bulletin-Coronavirus.pdf

Pulmonology

International Pulmonologist’s Consensus On Covid-19

Pulmonologist’s from different nations affected by this disease joined hands to frame this consensus on prevention and treatment aspects of this disease.

Please note: These materials are regularly updated based on new scientific findings as the epidemic evolves. Last updated: Update in progress currently: estimated completion for next release of new resources/information 10 April 2020 7 pm EST